Overview of Biomarkers and Surrogate Endpoints in Drug Development
There are numerous factors that recommend the use of biomarkers in drug development including the ability to provide a rational basis for selection of lead compounds, as an aid in determining or refining mechanism of action or pathophysiology, and the ability to work towards qualification and use of...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2002-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2002/929274 |